Statin Use, Incident Dementia and Alzheimer Disease in Elderly African Americans

Bibliographic Data

ID15315185
AuthorsMBChB Hugh C Hendrie (Indiana University, corresponding author), MBChB DSc Hugh C Hendrie, Ann Marie Hake (0000-0001-7134-5485, University School), MD Ann Hake, Kathleen A Lane (0000-0001-8784-2590, Indiana University), KATHLEEN LANE (0000-0003-0759-6321), BA Christianna Purnell (Indiana University), Frederick W Unverzagt (0000-0001-9297-1186, Indiana University), Frederick Unverzagt, Valerie Smith‐Gamble (Indiana University), MD Valerie Smith-Gamble, Jill R Murrell (0000-0002-1885-8385, Indiana University), Jill Murrell, MBChB Adesola Ogunniyi (University of Ibadan), Melissa Baiyewu (University of Ibadan), MBBS Olusegun Baiyewu, Chris Callahan (Indiana University School of Medicine), MD Chris Callahan, Andrew J Saykin (0000-0002-1376-8532, Indiana University), PsyD Andrew Saykin, Stanley Taylor (Indiana University School of Medicine), Kathleen Hall (0000-0001-9607-0043, University School), Sujuan Gao (0000-0002-6741-6380, Indiana University School of Medicine)
Year2015
Volume25
Issue3
Pages345-345
Publication date2015-08-05
Peer ReviewedYes
Open AccessNo
TypeARTICLE
VenueEthnicity & Disease (JOURNAL)
Journal identifiersISSN: 1049-510X • E-ISSN: 1945-0826
PublisherEthnicity & Disease, Inc (PUBLISHER)
DOI10.18865/ed.25.3.345
PMID26673814
OpenAlexW1877458684
LanguageEN
Citations received1
References cited3

Consistent use of statin medications during eight years of follow-up resulted in significantly reduced risk for incident AD and a trend toward reduced risk for incident dementia

Alzheimer's disease · Dementia · Disease · Hydroxymethylglutaryl-CoA Reductase Inhibitors · Statin · Diabetes, Cardiovascular Risks, and Lipoproteins · Lipoproteins and Cardiovascular Health · Medicine · Pharmaceutical Practices and Patient Outcomes · Gerontology · Internal Medicine

Tools

Open DOISci-HubOpen Access